Terms: = Breast cancer AND TG, Thyroglobulin AND Treatment
171 results:
1. Deep learning for high-resolution dose prediction in high dose rate brachytherapy for breast cancer treatment.
Quetin S; Bahoric B; Maleki F; Enger SA
Phys Med Biol; 2024 Apr; 69(10):. PubMed ID: 38604185
[No Abstract] [Full Text] [Related]
2. Effect of 2-methoxyestradiol on mammary tumor initiation and progression.
Peta KT; Durandt C; van Heerden MB; Joubert AM; Pepper MS; Ambele MA
Cancer Rep (Hoboken); 2024 Apr; 7(4):e2068. PubMed ID: 38600057
[TBL] [Abstract] [Full Text] [Related]
3. Short-term effectiveness and potential factors of ustekinumab based on real-world data in Chinese psoriasis patients.
Li X; Xie X; Li J; Hu J; Hu K; Tan M; Yang J; Deng S; Liu Y; Zhang M; Kuang Y; Chen J; Liao L; Zhu W
J Dermatolog Treat; 2024 Dec; 35(1):2321188. PubMed ID: 38531383
[TBL] [Abstract] [Full Text] [Related]
4. Development of erlotinib-loaded nanotransferosomal gel for the topical treatment of ductal carcinoma
Mangla B; Mittal P; Kumar P; Javed S; Ahsan W; Aggarwal G
Nanomedicine (Lond); 2024 Apr; 19(10):855-874. PubMed ID: 38440976
[TBL] [Abstract] [Full Text] [Related]
5. Hemostatic imbalance induced by tamoxifen in estrogen receptor-positive breast cancer patients: An observational study.
Didembourg M; Reda S; Oldenburg J; Rühl H; Douxfils J; Morimont L
Int J Lab Hematol; 2024 Jun; 46(3):546-554. PubMed ID: 38296772
[TBL] [Abstract] [Full Text] [Related]
6. Mucin-1-Targeted Chimeric Antigen Receptor T Cells Are Effective and Safe in Controlling Solid Tumors in Immunocompetent Host.
Zhou R; Wu ST; Yazdanifar M; Williams C; Sanders A; Brouwer C; Maher J; Mukherjee P
J Immunother; 2024 Apr; 47(3):77-88. PubMed ID: 38270462
[TBL] [Abstract] [Full Text] [Related]
7. Retrospective case-control study examining the relationship between recurrence-free survival and changes in pre- and post-radioiodine therapy serum thyroglobulin levels in patients with differentiated thyroid cancer.
Watanabe K; Igarashi T; Uchiyama M; Ishigaki T; Ojiri H
Jpn J Radiol; 2024 Apr; 42(4):391-397. PubMed ID: 38212512
[TBL] [Abstract] [Full Text] [Related]
8. Lipid changes during endocrine therapy in early-stage breast cancer patients: A real-world study.
Li Y; Deng Z; Wang Y; Shen S
Lipids Health Dis; 2024 Jan; 23(1):9. PubMed ID: 38191454
[TBL] [Abstract] [Full Text] [Related]
9. Vitamin D inhibits tamoxifen-induced non-alcoholic fatty liver disease through a nonclassical estrogen receptor/liver X receptor pathway.
Wu M; Wang J; Zhou W; Wang M; Hu C; Zhou M; Jiao K; Li Z
Chem Biol Interact; 2024 Feb; 389():110865. PubMed ID: 38191086
[TBL] [Abstract] [Full Text] [Related]
10. Surgical outcomes of endoscopic thyroidectomy approaches for thyroid cancer: a systematic review and network meta-analysis.
Li X; Ding W; Zhang H
Front Endocrinol (Lausanne); 2023; 14():1256209. PubMed ID: 38111707
[TBL] [Abstract] [Full Text] [Related]
11. Constructing a nomogram based on the distribution of thyroid nodules and suspicious lateral cervical lymph nodes in fine-needle aspiration biopsies to predict metastasis in papillary thyroid carcinoma.
Liu SQ; Feng JW; Yan ZT; Xing XX; Jiang WY; Jiang Y; Qian F; Xing W
Front Endocrinol (Lausanne); 2023; 14():1242061. PubMed ID: 38089614
[TBL] [Abstract] [Full Text] [Related]
12. The interplay between tamoxifen and endoxifen plasma concentrations and coagulation parameters in patients with primary breast cancer.
Buijs SM; van Dorst DCH; Kruip MJHA; van den Akker RFP; Cheung KL; Porrazzo R; Oomen-de Hoop E; Jager A; Koolen SLW; Versmissen J; Jan Danser AH; Versteeg HH; Bos MHA; Mathijssen RHJ
Biomed Pharmacother; 2024 Jan; 170():115969. PubMed ID: 38042112
[TBL] [Abstract] [Full Text] [Related]
13. Design and fabrication of a magnetic nanobiocomposite based on flaxseed mucilage hydrogel and silk fibroin for biomedical and in-vitro hyperthermia applications.
Radinekiyan F; Eivazzadeh-Keihan R; Naimi-Jamal MR; Aliabadi HAM; Bani MS; Shojaei S; Maleki A
Sci Rep; 2023 Nov; 13(1):20845. PubMed ID: 38012184
[TBL] [Abstract] [Full Text] [Related]
14. Targeting altered calcium homeostasis and uncoupling protein-2 promotes sensitivity in drug-resistant breast cancer cells.
Balakrishnan P; Arasu A; Velusamy T
J Biochem Mol Toxicol; 2024 Jan; 38(1):e23575. PubMed ID: 37920924
[TBL] [Abstract] [Full Text] [Related]
15. Robust Identification of Differential Gene Expression Patterns from Multiple Transcriptomics Datasets for Early Diagnosis, Prognosis, and Therapies for breast cancer.
Tuly KF; Hossen MB; Islam MA; Kibria MK; Alam MS; Harun-Or-Roshid M; Begum AA; Hasan S; Mahumud RA; Mollah MNH
Medicina (Kaunas); 2023 Sep; 59(10):. PubMed ID: 37893423
[No Abstract] [Full Text] [Related]
16. Correlation between serum lipid levels and endocrine resistance in patients with ER-positive breast cancer.
Sun H; Hu C; Zheng X; Zhuang J; Wei X; Cai J
Medicine (Baltimore); 2023 Oct; 102(41):e35048. PubMed ID: 37832070
[TBL] [Abstract] [Full Text] [Related]
17. Construction of the systemic anticancer immune environment in tumour-bearing humanized mouse by using liposome-encapsulated anti-programmed death ligand 1 antibody-conjugated progesterone.
Kametani Y; Ito R; Ohshima S; Manabe Y; Ohno Y; Shimizu T; Yamada S; Katano N; Kirigaya D; Ito K; Matsumoto T; Tsuda B; Kashiwagi H; Goto Y; Yasuda A; Maeki M; Tokeshi M; Seki T; Fukase K; Mikami M; Ando K; Ishimoto H; Shiina T
Front Immunol; 2023; 14():1173728. PubMed ID: 37492571
[TBL] [Abstract] [Full Text] [Related]
18. Increased plasma lipids in triple-negative breast cancer and impairment in HDL functionality in advanced stages of tumors.
Sawada MIBAC; de Fátima Mello Santana M; Reis M; de Assis SIS; Pereira LA; Santos DR; Nunes VS; Correa-Giannella MLC; Gebrim LH; Passarelli M
Sci Rep; 2023 Jun; 13(1):8998. PubMed ID: 37268673
[TBL] [Abstract] [Full Text] [Related]
19. Physapruin A Exerts Endoplasmic Reticulum Stress to Trigger breast cancer Cell Apoptosis via Oxidative Stress.
Yu TJ; Shiau JP; Tang JY; Farooqi AA; Cheng YB; Hou MF; Yen CH; Chang HW
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240198
[No Abstract] [Full Text] [Related]
20. Targeting the inward rectifier potassium channel 5.1 in thyroid cancer: artificial intelligence-facilitated molecular docking for drug discovery.
Yang X; Wu Y; Xu S; Li H; Peng C; Cui X; Dhoomun DK; Wang G; Xu T; Dong M; Li X; Du Y
BMC Endocr Disord; 2023 May; 23(1):113. PubMed ID: 37208644
[TBL] [Abstract] [Full Text] [Related]
[Next]
